Capsaicin Transdermal Patch and Sibrafiban: Interaction Details
- Capsaicin Transdermal Patch
- Aspercreme Warming PatchCoralite Medicated Heat PatchMedirelief Hot Patch +13 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Capsaicin Transdermal Patch and Sibrafiban interaction:
Capsaicin Transdermal Patch
- Aspercreme Warming Patch
- Coralite Medicated Heat Patch
- Medirelief Hot Patch
- Qutenza Patch
- Salonpas Pain Relieving Hot Patch
- Satogesic Hot Patch
- Solistice Hot Patch
- Qutenza
- WellPatch
- Satogesic Hot
- Menthac Arthritis Cream with Capsaicin
- Zostrix
- Red Hot
- Zostrix Sports
- Castiva Warming
- Capzasin-P
Sibrafiban
We don't have a drug information page for Sibrafiban yet. Have a question about Sibrafiban? Ask a pharmacist, free →
What Happens When You Take Capsaicin Transdermal Patch With Sibrafiban
What can happen when they are taken together (rated Moderate)
Increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
In theory, combining capsaicin with agents could raise the likelihood of bleeding. Compared with Americans, Thais, whose diets routinely include capsicum, showed lower fibrinogen levels,1 and capsicum was found to enhance fibrinolytic activity in Thai individuals.2
In rat exposed to capsaicin, platelet aggregation was inhibited.3 Whether these effects of capsaicin on fibrinolytic activity and platelet aggregation matter clinically has not been established. Caution is recommended when capsaicin is used alongside antiplatelet agents until this possible interaction is more fully characterized.45
The Capsaicin Transdermal Patch and Sibrafiban Interaction, Explained
Sibrafiban is an investigational medicine, studied in clinical trials, that keeps from sticking together. This helps prevent clots, but it also makes bleeding a bit easier. Some early studies suggest capsaicin, the warming ingredient in hot pepper patches, might also slightly thin the blood. Putting the two together could, in theory, add to the bleeding risk.
The good news is that this idea comes mostly from diet studies and lab work in rats, not from real patients. A skin patch also puts very little capsaicin into your blood. Keep using your medicines as prescribed, and let your pharmacist or doctor know you use a capsaicin patch so your care team can keep an eye on things.
Mechanism: effect. Capsaicin has been reported to inhibit aggregation (rat platelets) and enhance fibrinolytic activity (dietary capsicum in Thai populations, lower fibrinogen). Sibrafiban is an oral GP IIb/IIIa receptor (investigational) that inhibits platelet aggregation. Combined use may theoretically increase bleeding risk.
- Evidence: Theoretical; human dietary and animal in vitro data only. Clinical significance unknown.
- Onset: Unspecified.
- Exposure: Systemic from transdermal capsaicin is generally low; high-concentration (8%) patches yield transient, low .
- Management: Monitor closely for signs of bleeding (bruising, mucosal or bleeding). Consider minimizing appreciable capsaicin exposure before initiation per documented guidance.
See the 5 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Capsaicin Transdermal Patch and Sibrafiban Interact
The likely mechanism
Capsaicin may inhibit aggregation and enhance fibrinolytic activity
How to Manage the Capsaicin Transdermal Patch and Sibrafiban Interaction
This possible interaction is based on limited, early evidence, and your care team can manage it.
- What your team may do: watch you more closely for signs of bleeding, and talk with you about how much capsaicin you use, especially before starting an medicine.
- What you can do: keep taking your medicines as prescribed. Tell your pharmacist or prescriber that you use a capsaicin patch (or eat a lot of hot peppers).
- Call your team if you notice unusual bruising, nosebleeds, bleeding gums, blood in urine, or black stools.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Capsaicin Transdermal Patch or Sibrafiban need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
Literature Reports
2 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
The relationship between high fibrinolytic activity and daily capsicum ingestion in Thais
In 88 Thai subjects, euglobulin lysis time (ELT) (mean +/- SD equal to 167 +/- 66.84 minutes) was significantly lower than that observed in 55 American Caucasians (mean +/- SD equal to 254 +/- 126.70 minutes) (p less than 0.001). Among Thais who regularly consume capsicum with meals, fibrinogen levels were 250.7 +/- 84.27 mg/100 mL, compared with 292.3 +/- 88.28 mg/100mL in Americans (p less than 0.01).1
-
Report 2 · Study title
Enhanced fibrinolytic activity after capsicum ingestion
Diminished fibrinolytic activity in Thais has been associated with daily ingestion of capsicum. In an experimental group, Thai medical students (n equal to 16) received two teaspoons of ground fresh capsicum (Capsicum frutescens) along with 200 grams of noodles and were compared with subjects who consumed the same quantity of noodles without capsicum (n equal to 4).
In the 16 subjects who ingested capsicum, fibrinolytic activity measured by euglobulin lysis time (ELT) was significantly shortened (p equal to 0.005) immediately following the meal, although this effect persisted for less than 30 minutes. No significant change in fibrinogen levels was observed.2
Capsaicin Transdermal Patch and Sibrafiban: Common Questions
How serious is the Capsaicin Transdermal Patch and Sibrafiban interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How is the Capsaicin Transdermal Patch and Sibrafiban interaction managed?
This possible interaction is based on limited, early evidence, and your care team can manage it. What your team may do: watch you more closely for signs of bleeding, and talk with you about how much capsaicin you use, especially before starting an medicine. What you can do: keep taking your medicines as prescribed. Tell your pharmacist or prescriber that you use a capsaicin patch (or… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Capsaicin Transdermal Patch and Sibrafiban Interaction
Ask in your own words about taking Capsaicin Transdermal Patch and Sibrafiban together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (5)
- Visudhiphan S, Poolsuppasit S, Piboonnukarintr O, et al: The relationship between high fibrinolytic activity and daily capsicum ingestion in Thais. Am J Clin Nutrition 1982; 35:1452-1458. PubMed
- Wasantapruek S, Poolsuppasit S, & Piolnukarintr O: Enhanced fibrinolytic activity after capsicum ingestion. N Engl J Med 1974; 290:1259-1260. DOI
- Wang JP, Hsu MF, & Teng CM: Antiplatelet effect of capsaicin. Thromb Res 1984; 36:497-507. DOI
- Norred CL & Brinker F: Potential coagulation effects of preoperative complementary and alternative medicines. Alt Ther 2001; 7(6):58-67.
- Heck AM, DeWitt BA, & Lukes AL: Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 2000; 57(13):1221-1227. DOI
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring. This interaction.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.